News about "clinical trial "

Akeso's B7-H3 ADC AK157D1 Cleared for Phase I Clinical Trial in China

Akeso has received NMPA clinical trial clearance for AK157D1, a next-generation B7-H3-targeting ADC, paving the way for a Phase I study in patients with advanced solid tumours in China.

Clinical Trial | 24/08/2026 | By News Bureau

Akeso Initiates Phase 2 Trial of TROP2/Nectin-4 Bispecific ADC in Advanced Breast Cancer

Akeso has dosed the first patient in a Phase 2 study of AK146D1 combined with ivonescimab, advancing its next-generation “IO2.0 + ADC2.0” approach for advanced breast cancer.

Clinical Trial | 10/08/2026 | By News Bureau

World-First Fridge-Free Tetanus-Diphtheria Vaccine Trial Shows Promising Results

Stablepharma’s SPVX02 remains potent for up to two years at temperatures of up to 30°C, potentially reducing cold-chain dependence, vaccine wastage and barriers to immunisation in remote regions.

Clinical Trial | 10/08/2026 | By News Bureau

4Moving Biotech Completes Enrollment in Phase 2a Trial of Investigational Knee Osteoarthritis Therapy

4Moving Biotech has completed patient enrollment in its global Phase 2a INFLAM MOTION trial, assessing the safety and efficacy of investigational therapy 4P004 for inflammatory knee osteoarthritis.

Clinical Trial | 05/08/2026 | By News Bureau |  1303

GlycoNex Doses First Patient in Phase 1 Trial of GNX1021

GlycoNex dosed the first patient in its phase 1 trial of GNX1021, advancing its glycan-directed Antibody Drug Conjugate (ADC) while exploring global licensing and co-development deals.

Clinical Trial | 03/08/2026 | By News Bureau

ProMIS Neurosciences Reports Positive Interim Phase 1b Results for Alzheimer's Therapy PMN310

ProMIS Neurosciences has reported positive six-month interim data from its Phase 1b PRECISE-AD trial, with PMN310 demonstrating a favourable safety profile, no ARIA-E cases and encouraging biomarker trends in patients with Alzheimer's disease.

Clinical Trial | 30/07/2026 | By News Bureau |  150

Sanofi to not Submit Amlitelimab in Atopic Dermatitis for Global Regulatory Reviews

Sanofi will not seek global regulatory approval for amlitelimab in Atopic Dermatitis (AD) after efficacy and safety data did not support further development.

Clinical Trial | 27/07/2026 | By News Bureau

Healx Doses First Patient in Phase 1/2 Trial of AI-Discovered Therapy for Relapsed Osteosarcoma

Healx has dosed the first patient in its Phase 1/2 trial of AI-developed investigational therapy HLX-4310, marking a milestone in the development of novel treatments aimed at preventing metastatic recurrence in osteosarcoma and other rare cancers.

Clinical Trial | 24/07/2026 | By News Bureau

Anteris Technologies Global Corp. Begins US Enrollment in PARADIGM Trial for DurAVR Heart Valve

Anteris marks first patients successfully treated in US as global trial evaluates safety and effectiveness of DurAVR THV against existing transcatheter aortic valve therapies.

Clinical Trial | 06/05/2026 | By News Bureau |  141

Cellenkos Receives US FDA IND Clearance for CK0802 Phase 1b/ 2a Trial in GVHD

The US Food and Drug Administration (FDA) clears Cellenkos Inc IND for CK0802, a first-in-class off-the-shelf Treg therapy, advancing to a phase 1b/2a trial in steroid-refractory Graft-Versus-Host Disease (GVHD).

Clinical Trial | 06/05/2026 | By News Bureau |  179